Testing a new tablet for chronic bladder infections in women
Treatments studied
Part of Infections, Kidney & urinary clinical trials.
This trial tests an investigational tablet called Fluorothiazinone for women with chronic bladder infections (cystitis) that keep coming back. It aims to see if the drug is safe and helps relieve symptoms like pain and frequent urination.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman at least 18 years old.
- You have had bladder infections that keep coming back (chronic cystitis).
- You are currently having symptoms like pain when peeing, needing to pee often, or feeling you can't empty your bladder fully.
- You agree to use effective birth control if you could become pregnant, and have a negative pregnancy test before starting.
- You have not taken a long-acting antibiotic (one taken once a day) in the last 12 hours.
- You are willing to follow the study procedures and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two approaches to prevent repeat bladder infections in postmenopausal women: a daily antibiotic pill or a vaginal tablet containing healthy bacteria and estrogen. The goal is to see which method works better over 6 months.
This Phase 2 trial tests LBP-EC01 to treat a bladder infection (UTI) caused by drug-resistant E. coli. It may help by targeting the specific bacteria that make UTIs harder to cure with common antibiotics.
This trial compares a new treatment approach—high-dose antibiotics combined with methenamine hippurate—against standard care for women with chronic urinary tract infections (UTIs). It aims to find if the combination works better at relieving persistent symptoms like pain and frequent urination.
This study compares two common antibiotics, nitrofurantoin and fosfomycin, to see which works better for treating bladder infections (cystitis) in women. If you have a bladder infection, this trial will help find the best treatment for you.
This study compares taking a daily antibiotic (nitrofurantoin) alone versus having a procedure that cauterizes bladder areas (fulguration) plus the same daily antibiotic, to see which is better at preventing recurrent urinary tract infections in women.
This trial tests a therapy (called GAG therapy) to prevent repeat urinary tract infections (UTIs) in adult women. It compares how similar the results are to a well-known antibiotic standard (nitrofurantoin) to see if it works reliably.
Hear when a new E Coli Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.